文献速递肾癌与肾肿瘤

肾癌手术后慢性肾病患者的生存分析

Analysis of survival for patients with chronic kidney disease primarily related to renal cancer surgery.
PubMed 文献 · BJU Int · 2017-09-10

本研究回顾性分析了1997至2008年间在本中心接受肾癌手术的4246例患者,中位随访9.4年。重点评估因手术导致慢性肾病(CKD-S)患者的非肾癌相关生存(NRCRS),发现新基线GFR低于45 mL/min/1.73 m2者生存显著受损,提示CKD-S存在异质性。

要点

  • CKD-S患者中新基线GFR<45者NRCRS显著低于无CKD或GFR 45-60者(P≤0.004)。
  • 年龄、性别、心脏病和新基线GFR均独立关联CKD-S患者的NRCRS(P≤0.02)。
  • CKD-S异质性提示对高危患者选择部分或根治性肾切除术可能有意义。

核心结论

  • CKD-S患者存在异质性,新基线GFR降低者生存受损,尤其当GFR<45 mL/min/1.73 m2时。
  • 研究结果可能对高危CKD-S患者选择部分或根治性肾切除术有影响。

研究设计与样本

  • 回顾性分析1997至2008年在本中心接受肾癌手术的4246例患者,中位随访9.4年(IQR 7.3-11.0)。
  • 新基线GFR定义为肾癌手术后至6周内最低值与最高值之间的最高GFR。
  • 分为三组:无CKD组(新基线GFR≥60 mL/min/1.73 m2)、CKD-S组(术前GFR≥60但新基线GFR<60 mL/min/1.73 m2)、CKD-M/S组(术前及新基线GFR均<60 mL/min/1.73 m2)。

主要发现

  • 4246例患者中,CKD-S组931例,CKD-M/S组1113例,无CKD组2202例;部分肾切除术占54%,根治性肾切除术占46%。
  • CKD-S组中新基线GFR 45-60 mL/min/1.73 m2者641例,<45 mL/min/1.73 m2者290例。
  • Kaplan-Meier分析显示CKD-S且GFR<45 mL/min/1.73 m2者的NRCRS显著低于无CKD组和CKD-S且GFR 45-60 mL/min/1.73 m2组(均P≤0.004),竞争风险分析证实(P<0.001)。
  • 年龄、性别、心脏病和新基线GFR均独立关联CKD-S患者的NRCRS(均P≤0.02)。

临床怎么用

  • 作者认为CKD-S异质性及新基线GFR降低与生存受损的关联可能对高危患者选择部分或根治性肾切除术有影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate predictors of long-term survival for patients with chronic kidney disease primarily due to surgery (CKD-S). Patients with CKD-S have generally good survival that approximates patients who do not have CKD even after renal cancer surgery (RCS), yet there may be heterogeneity within this cohort. PATIENTS AND METHODS: From 1997 to 2008, 4 246 patients underwent RCS at our centre. The median (interquartile range [IQR]) follow-up was 9.4 (7.3-11.0) years. New baseline glomerular filtration rate (GFR) was defined as highest GFR between nadir and 6 weeks after RCS. We retrospectively evaluated three cohorts: no-CKD (new baseline GFR of ≥60 mL/min/1.73 m2 ); CKD-S (new baseline GFR of <60 mL/min/1.73 m2 but preoperative GFR of ≥60 mL/min/1.73 m2 ); and CKD due to medical aetiologies who then require RCS (CKD-M/S, preoperative and new baseline GFR both <60 mL/min/1.73 m2 ). Analysis focused primarily on non-renal cancer-related survival (NRCRS) for the CKD-S cohort. Kaplan-Meier analysis assessed the longitudinal impact of new baseline GFR (45-60 mL/min/1.73 m2 vs <45 mL/min/1.73 m2 ) and Cox regression evaluated relative impact of preoperative GFR, new baseline GFR, and relevant demographics/comorbidities. RESULTS: Of the 4 246 patients who underwent RCS, 931 had CKD-S and 1 113 had CKD-M/S, whilst 2 202 had no-CKD even after RCS. Partial/radical nephrectomy (PN/RN) was performed in 54%/46% of the patients, respectively. For CKD-S, 641 patients had a new baseline GFR of 45-60 mL/min/1.73 m2 and 290 had a new baseline GFR of <45 mL/min/1.73 m2 . Kaplan-Meier analysis showed significantly reduced NRCRS for patients with CKD-S with a GFR of <45 mL/min/1.73 m2 compared to those with no-CKD or CKD-S with a GFR of 45-60 mL/min/1.73 m2 (both P ≤ 0.004), and competing risk analysis confirmed this (P < 0.001). Age, gender, heart disease, and new baseline GFR were all associated independently with NRCRS for patients with CKD-S (all P ≤ 0.02). CONCLUSION: Our data suggest that CKD-S is heterogeneous, and patients with a reduced new baseline GFR have compromised survival, particularly if <45 mL/min/1.73 m2 . Our findings may have implications regarding choice of PN/RN in patients at risk of developing CKD-S.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Wu J, Suk-Ouichai C, Dong W, et al. Analysis of survival for patients with chronic kidney disease primarily related to renal cancer surgery. BJU Int. 2017. PMID: 28834125. doi:10.1111/bju.13994

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。